is allulose a glp-1 agonist The Metabolic and Endocrine Effects of 12-Week Allulose-Rich Diet Is allulose a GLP-1 agonist?

doi: 10.1016/j.jconrel.2014.10.026 [6] Zhao Z, Hu Y, Hoerle R, et al

Edison PJAs, dementia: Neuroinflammation in Alzheimers disease: current evidence and future directions

this difference may result from a ~5x stronger effect produced by GLP-1 analogs, compared to DPP-4 inhibitors (Charbonnel & Cariou, 2011) No change in weight Contraindications: type I diabetes (these patients lack pancreatic beta cells) diabetic ketoacidosis (it would not be effective for treating this condition) an association between DPP-4 inhibitors and heart failure has been observed for two members of this drug class in patients with type 2 DM and atherosclerosis

By blocking NNMT, the compound is associated with preserved NAD+ levels and reduced fat storage, alongside improvements in cellular energy utilization and insulin sensitivity